Mapping of hippocampal pH and neurochemicals from in vivo multi-voxel 31P study in healthy normal young male/female, mild cognitive impairment, and Alzheimer's disease.

Magnetic resonance spectroscopy (MRS) plays an important role in the understanding of membrane and energy metabolism. The outcome of MRS experiments helps to derive important cellular conditions (e.g., intracellular pH, energy, membrane metabolism, etc.), which are directly related to neuronal health. We present a novel multi-voxel 31P MRS imaging experimental scheme along with an advanced 31P signal processing technique to determine the pH and neurochemicals from both hippocampal areas in shorter time (13.2 min) for subjects (e.g. healthy young male/female, mild cognitive impairment (MCI) and Alzheimer's disease (AD)). Significant (p = 0.005) decrease of phosphomonoester (PME) and increase of phosphodiester (PDE) (p < 0.001), γ-ATP (0.008), and PCr (p = 0.001) levels in the left hippocampus of AD patients (n = 6) compared to the control subjects (n = 12) were found based on post-hoc ANOVA. On the other hand, in the right hippocampus, decrease in PME (p = 0.008) and increase in PDE (p < 0.001) were significant between AD patients and controls. In case of AD subjects, pH in the left hippocampus is increased towards alkaline side compared to MCI but did not reach statistical significance level. The pH (left hippocampus) in AD is found to be negatively correlated (r = -0.829, p = 0.042) with PCr level (left hippocampus) in AD subjects. In the left hippocampus, the increase in pH to alkaline range (in normal aging, pH is decreased to acidic range) along with statistically significant increments of PCr, γ-ATP, and PDE as well as decrease of PME in AD subjects provide extremely crucial clinical information, which can be used as biomarker for AD and potentially aid in the diagnosis.

[1]  D. Twieg,et al.  Is the intracellular pH different from normal in the epileptic focus of patients with temporal lobe epilepsy? , 1996, Neurology.

[2]  P. Barker,et al.  Magnesium and pH imaging of the human brain at 3.0 Tesla , 1999, Magnetic resonance in medicine.

[3]  T. Inubushi,et al.  Effect of photic stimulation on energy metabolism in the human brain measured by 31P-MR spectroscopy. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[4]  K. Meguro,et al.  Five-year retrospective changes in hippocampal atrophy and cognitive screening test performances in very mild Alzheimer's disease: the Tajiri Project , 2002, Neuroradiology.

[5]  T. Inubushi,et al.  Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. , 1993, Journal of affective disorders.

[6]  D. Schomburg,et al.  BRENDA: a resource for enzyme data and metabolic information. , 2002, Trends in biochemical sciences.

[7]  W. Markesbery,et al.  Four-Hydroxynonenal, a Product of Lipid Peroxidation, is Increased in the Brain in Alzheimer’s Disease , 1998, Neurobiology of Aging.

[8]  Pravat K. Mandal,et al.  Magnetic Resonance Spectroscopy (MRS) and Its Application in Alzheimer's Disease , 2007 .

[9]  R G Shulman,et al.  Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy , 1985, Neurology.

[10]  R. Lenkinski,et al.  Brain pH in head injury: An image‐guided 31P magnetic resonance spectroscopy study , 1990, Annals of neurology.

[11]  J. Pettegrew,et al.  Considerations for brain pH assessment by 31P NMR. , 1988, Magnetic resonance imaging.

[12]  Christine Fennema-Notestine,et al.  Left hippocampal volume loss in Alzheimer's disease is reflected in performance on odor identification: a structural MRI study. , 2003, Journal of the International Neuropsychological Society : JINS.

[13]  Jimmy D Bell,et al.  Phosphorus-31 brain MR spectroscopy in women during and after pregnancy compared with nonpregnant control subjects. , 2005, AJNR. American journal of neuroradiology.

[14]  K. Blennow,et al.  Combination of Hippocampal Volume and Cerebrospinal Fluid Biomarkers Improves Predictive Value in Mild Cognitive Impairment , 2010, Dementia and Geriatric Cognitive Disorders.

[15]  S. Barnes,et al.  active site modifications of the brain isoform of creatine kinase by 4-hydroxy-2-nonenal correlate with reduced enzyme activity: mapping of modified sites by Fourier transform-ion cyclotron resonance mass spectrometry. , 2007, Chemical research in toxicology.

[16]  H. Sauer,et al.  Do neuroleptics alter the cerebral intracellular pH value in schizophrenics?—a 31P-MRS study on three different patient groups , 2002, Psychiatry Research: Neuroimaging.

[17]  Pravat K Mandal,et al.  In vivo proton magnetic resonance spectroscopic signal processing for the absolute quantitation of brain metabolites. , 2012, European journal of radiology.

[18]  D. Butterfield,et al.  Oxidative Modification of Creatine Kinase BB in Alzheimer’s Disease Brain , 2000, Journal of neurochemistry.

[19]  B. Haley,et al.  Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning. , 1998, Brain research. Molecular brain research.

[20]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[21]  Peter Stoeter,et al.  Functional implications of hippocampal volume and diffusivity in mild cognitive impairment , 2005, NeuroImage.

[22]  S. Blüml,et al.  Developmental changes in choline‐ and ethanolamine‐containing compounds measured with proton‐decoupled 31P MRS in in vivo human brain , 1999, Magnetic resonance in medicine.

[23]  Thanh-Thu T. Tran,et al.  Hippocampal volume and the Mini-Mental State Examination in the diagnosis of amnestic mild cognitive impairment. , 2007, AJR. American journal of roentgenology.

[24]  Manjari Tripathi,et al.  Brain oxidative stress: detection and mapping of anti-oxidant marker 'Glutathione' in different brain regions of healthy male/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy. , 2012, Biochemical and biophysical research communications.

[25]  J. Pettegrew,et al.  Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study , 1994, Neurobiology of Aging.

[26]  M. Marie-cardine,et al.  In vivo hippocampal 31P NMR metabolites in Alzheimer's disease and ageing , 1997, European Psychiatry.

[27]  Nicholas Lange,et al.  Age‐related changes in brain energetics and phospholipid metabolism , 2010, NMR in biomedicine.

[28]  T. Inubushi,et al.  Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder , 1994, Psychiatry Research: Neuroimaging.

[29]  G. Fein,et al.  31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia , 1992, Biological Psychiatry.

[30]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[31]  Himanshu Akolkar,et al.  A new experimental approach and signal processing scheme for the detection and quantitation of ³¹P brain neurochemicals from in vivo MRS studies using dual tuned (¹H/³¹P) head coil. , 2011, Biochemical and biophysical research communications.

[32]  Wagner F. Gattaz,et al.  Reduced phospholipid breakdown in Alzheimer’s brains: a 31P spectroscopy study , 2005, Psychopharmacology.

[33]  N. Kato,et al.  Reduced intracellular pH in the basal ganglia and whole brain measured by 31P‐MRS in bipolar disorder , 2004, Psychiatry and clinical neurosciences.

[34]  N. Kato,et al.  Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity , 1998, European Archives of Psychiatry and Clinical Neuroscience.

[35]  J S Taylor,et al.  Proton‐decoupled 31P chemical shift imaging of the human brain in normal volunteers , 1993, NMR in biomedicine.

[36]  D. Kintner,et al.  31P-MRS-Based Determination of Brain Intracellular and Interstitial pH: Its Application to In Vivo H+ Compartmentation and Cellular Regulation during Hypoxic/Ischemic Conditions , 2000, Neurochemical Research.

[37]  N. Bresolin,et al.  Parkinson's Disease and Brain Mitochondrial Dysfunction: A Functional Phosphorus Magnetic Resonance Spectroscopy Study , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  N. Kato,et al.  Age-dependent alteration of metabolic response to photic stimulation in the human brain measured by 31 P MR-spectroscopy , 1999, Brain Research.